Loading
  • All
  • 0 - 9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
You're currently filtering by:
Major update to type 2 diabetes care

Major update to type 2 diabetes care

20 Aug 2025 National Institute for Health & Care Excellence
Key changes include: Earlier use of newer medicines – SGLT-2 inhibitors (such as canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin) are now recommended as first-line options alongside met …
1 Results